AIM - AIM ImmunoTech Inc
IEX Last Trade
0.3481
-0.012 -3.390%
Share volume: 131,020
Last Updated: Fri 30 Aug 2024 09:35:34 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.36
-0.01
-3.28%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-15 | 2022-11-14 | 2023-03-31 | 2023-05-15 | 2023-08-14 | 2023-11-14 | 2024-04-01 | 2024-05-15 | |
| Assets | |||||||||
| Total Assets | 50.884 M | 46.285 M | 40.488 M | 37.462 M | 33.617 M | 27.861 M | 19.381 M | 16.189 M | |
| Current Assets | 46.045 M | 41.150 M | 36.321 M | 33.160 M | 28.869 M | 22.742 M | 14.556 M | 11.306 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 373.000 K | 805.000 K | 455.000 K | 548.000 K | 438.000 K | 263.000 K | 302.000 K | 364.000 K | |
| Short Term Investments | 373.000 K | 805.000 K | 455.000 K | 548.000 K | 438.000 K | 263.000 K | 302.000 K | 364.000 K | |
| Total Receivables | 0.000 | 0.000 | 1.676 M | 1.763 M | 33.000 K | 48.000 K | 1.184 M | 0.000 | |
| Current Cash | 41.772 M | 36.745 M | 34.190 M | 30.849 M | 28.398 M | 22.431 M | 13.070 M | 10.942 M | |
| Total Non-current Assets | 4.839 M | 5.135 M | 4.167 M | 4.302 M | 4.748 M | 5.119 M | 4.825 M | 4.883 M | |
| Property Plant Equipment | 127.000 K | 118.000 K | 195.000 K | 155.000 K | 145.000 K | 136.000 K | 127.000 K | 118.000 K | |
| Other Assets | 1.811 M | 2.138 M | 1.202 M | 1.457 M | 1.784 M | 2.102 M | 1.688 M | 1.688 M | |
| Intangible Assets | 2.012 M | 2.013 M | 1.941 M | 1.898 M | 2.038 M | 2.154 M | 2.313 M | 2.314 M | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 50.884 M | 46.285 M | 40.488 M | 37.462 M | 33.617 M | 27.861 M | 19.381 M | 16.189 M | |
| Total liabilities | 2.104 M | 3.590 M | 2.020 M | 2.473 M | 3.482 M | 5.259 M | 9.147 M | 11.363 M | |
| Total current liabilities | 1.368 M | 2.895 M | 1.361 M | 1.837 M | 2.885 M | 4.716 M | 8.652 M | 9.876 M | |
| Accounts Payable | 712.000 K | 957.000 K | 377.000 K | 963.000 K | 2.151 M | 2.788 M | 6.443 M | 6.567 M | |
| Other liabilities | 1.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 1.623 M | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 950.000 K | |
| Other liabilities | 1.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 48.780 M | 42.695 M | 38.468 M | 34.989 M | 30.135 M | 22.602 M | 10.234 M | 4.826 M | |
| Common stock | 48.034 M | 48.079 M | 48.081 M | 48.400 M | 48.411 M | 48.635 M | 48.895 M | 49.458 M | |
| Retained earnings | -369.772 M | -376.157 M | -380.546 M | -384.207 M | -389.116 M | -396.932 M | -409.508 M | -415.325 M |